SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John O'Neill who started this subject5/2/2003 8:57:50 AM
From: nigel bates  Read Replies (1) of 415
 
WALTHAM, Mass., May 2 /PRNewswire-FirstCall/ -- Essential Therapeutics, Inc. (OTC Bulletin Board: ETRX - News) announced today that it, along with its wholly-owned subsidiaries, Maret Corporation and The Althexis Company, Inc., filed for protection under Chapter 11 of the U.S. Bankruptcy Code. The filing was made in Wilmington, Delaware. Later today, the Company intends to file a Plan of Reorganization providing for payment in full of obligations owed to certain creditors and providing for the recapitalization of the Company as a privately-held entity...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext